Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 34 min ago
Peer-reviewedCC BY-NC-SA 4.0Journal of Clinical and Experimental Hematopathology : JCEH

Clinicopathological analysis of oral-cavity B-cell neoplasms: Comparison between non-immunosuppressive and immunosuppressive patients

  1. 1Department of Pathology, Tokai University School of Medicine, Isehara, Kanagawa, Japan, Department of Oral Surgery, Tokai University School of Medicine, Isehara, Kanagawa, Japan

Abstract

No comparative analysis of the infrequently occurring B-cell neoplasms (BCNs) in the oral cavity has yet been reported in patients with non-immunosuppressiveness or immunosuppressiveness. To identify any differences in clinicopathological findings between patients with non-immunosuppressiveness and those with immunosuppressiveness, we compared the clinicopathological characteristics of oral-cavity BCNs in these patient groups. The clinical characteristics of 39 patients were analyzed from hospital records, including 24 with non-immunosuppressiveness and 15 with immunosuppressiveness. Histological and immunohistochemical evaluation was performed using formalin-fixed paraffin-embedded tissue sections. Comparisons between the two groups were conducted using cross-tabulations and the chi-squared or Fisher exact test. In patients with non-immunosuppressiveness, diffuse large B-cell lymphoma (DLBCL) was the most common type (14/24, 58%), followed by mucosa-associated lymphoid tissue lymphoma (MALT-L, 4/24, 17%). In patients with immunosuppressiveness, EBV-positive mucocutaneous ulcers (EBV-MCU) were the most common type (9/15, 60%), followed by DLBCL (3/15, 20%) and polymorphic/lymphoplasmacytic infiltration (3/15, 20%). Macroscopic findings showed 21 masses (88%) and 3 ulcers (13%) in patients with non-immunosuppressiveness and 11 ulcers (73%) and 4 masses (27%) in patients with immunosuppressiveness. Immunohistochemistry revealed that BCNs in patients with non-immunosuppressiveness expressed EBER in only 1 case (1/22, 5%), whereas those in patients with immunosuppressiveness expressed EBER in all cases (15/15, 100%). Our macroscopic findings and EBV status allowed us to distinguish BCNs between patients with non-immunosuppressiveness and those with immunosuppressiveness.

Related

  1. Clinicopathological comparison of gastric cancer in young (<45 years) versus elderly (>60 years) patients: a single-center retrospective study.
    Junxuan Zhang, Rui Zhao, Qingshan Bai +2
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  2. Pulmonary Neoplasms with Pleuropulmonary Blastoma-like Features in Two Young Labrador Retrievers: Clinicopathological, Molecular and Comparative Characterisation.
    Louise van der Weyden, Bailey A Francis, Damon R Olson +10
    Veterinary sciencesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Cytomorphology of Hematolymphoid Neoplasms in Body Cavity Effusions: Diagnostic Value and Prognostic Implications - A Case Series.
    Preeti Agarwal, Mamta Dwivedi, Geeta Yadav +6
    Acta cytologicaPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Clinicopathological and molecular comparison of eosinophilic solid and cystic renal cell carcinoma and TFEB ‐amplified renal cell carcinoma: a comprehensive study of 15 cases
    Hayley Zullow, Melissa Y. Tjota, Jung Woo Kwon +1
    HistopathologyPeer-reviewedCC BY 4.0Full text1 citedOncologyPMC
  5. Clonal dynamic changes during the progression of myelodysplastic neoplasms to secondary acute myeloid leukemia: a paired-sample comparison
    Che-Wei Ou, Hsiao-Wen Kao, Tung-Liang Lin +4
    Clinical and Experimental MedicinePeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
BibTeX
@article{ishii2026clinicopathological,
  title = {{Clinicopathological analysis of oral-cavity B-cell neoplasms: Comparison between non-immunosuppressive and immunosuppressive patients}},
  author = {Yuuki Ishii and Mebae Ichikawa and Yusuke Kondo and Joaquim Carreras and Masashi Miyaoka and Yukie Yara Kikuchi and Takayuki Aoki and Yoshihide Ota and Naoya Nakamura},
  journal = {Journal of Clinical and Experimental Hematopathology : JCEH},
  year = {2026},
  month = jul,
  doi = {10.3960/jslrt.25015},
  url = {https://doi.org/10.3960/jslrt.25015},
  note = {CC BY-NC-SA 4.0},
}
RIS
TY  - JOUR
TI  - Clinicopathological analysis of oral-cavity B-cell neoplasms: Comparison between non-immunosuppressive and immunosuppressive patients
AU  - Yuuki Ishii
AU  - Mebae Ichikawa
AU  - Yusuke Kondo
AU  - Joaquim Carreras
AU  - Masashi Miyaoka
AU  - Yukie Yara Kikuchi
AU  - Takayuki Aoki
AU  - Yoshihide Ota
AU  - Naoya Nakamura
PY  - 2026
DA  - 2026/07/30
JO  - Journal of Clinical and Experimental Hematopathology : JCEH
DO  - 10.3960/jslrt.25015
UR  - https://doi.org/10.3960/jslrt.25015
AB  - No comparative analysis of the infrequently occurring B-cell neoplasms (BCNs) in the oral cavity has yet been reported in patients with non-immunosuppressiveness or immunosuppressiveness. To identify any differences in clinicopathological findings between patients with non-immunosuppressiveness and those with immunosuppressiveness, we compared the clinicopathological characteristics of oral-cavity BCNs in these patient groups. The clinical characteristics of 39 patients were analyzed from hospital records, including 24 with non-immunosuppressiveness and 15 with immunosuppressiveness. Histological and immunohistochemical evaluation was performed using formalin-fixed paraffin-embedded tissue sections. Comparisons between the two groups were conducted using cross-tabulations and the chi-squared or Fisher exact test. In patients with non-immunosuppressiveness, diffuse large B-cell lymphoma (DLBCL) was the most common type (14/24, 58%), followed by mucosa-associated lymphoid tissue lymphoma (MALT-L, 4/24, 17%). In patients with immunosuppressiveness, EBV-positive mucocutaneous ulcers (EBV-MCU) were the most common type (9/15, 60%), followed by DLBCL (3/15, 20%) and polymorphic/lymphoplasmacytic infiltration (3/15, 20%). Macroscopic findings showed 21 masses (88%) and 3 ulcers (13%) in patients with non-immunosuppressiveness and 11 ulcers (73%) and 4 masses (27%) in patients with immunosuppressiveness. Immunohistochemistry revealed that BCNs in patients with non-immunosuppressiveness expressed EBER in only 1 case (1/22, 5%), whereas those in patients with immunosuppressiveness expressed EBER in all cases (15/15, 100%). Our macroscopic findings and EBV status allowed us to distinguish BCNs between patients with non-immunosuppressiveness and those with immunosuppressiveness.
SN  - 1346-4280
SN  - 1880-9952
ER  -